Marc Landers - medical cannabis patient and advocate

[Marc Landers]

Hi and nice to meet you too.

I'm not sure exactly what you mean by this "Is it easy to share your readings as other sites I'm subscribed to..."

If you mean sharing my posts on other social media sites, it depends on the site. This forum and X are the easiest. Facebook allows my posts but I think it shadow bans them as I never get any engagement with my posts there. Instagram is a real pain, as they allow postings but no external links. Reddit is the worst.

Thanks for subscribing to my newsletter! If you find it useful, please share it with all your friends and family, for you never know who may be suffering in silence. It also helps spread the word about medical cannabis and helps end the stigma.

Thanks again and nice to meet you.

 

[Dooby Doo]

Hi and nice to meet you too.

I'm not sure exactly what you mean by this "Is it easy to share your readings as other sites I'm subscribed to..."

If you mean sharing my posts on other social media sites, it depends on the site. This forum and X are the easiest. Facebook allows my posts but I think it shadow bans them as I never get any engagement with my posts there. Instagram is a real pain, as they allow postings but no external links. Reddit is the worst.

Thanks for subscribing to my newsletter! If you find it useful, please share it with all your friends and family, for you never know who may be suffering in silence. It also helps spread the word about medical cannabis and helps end the stigma.

Thanks again and nice to meet you.

Thanks for the reply, when I find something that should be shared with others, sometimes I find I can't share it as there usually isn't a share button, you can only share the information by email to others. That's what I meant, I'm still waking up after a decent sleep last night

 

[Marc Landers]

Thanks for the reply, when I find something that should be shared with others, sometimes I find I can't share it as there usually isn't a share button, you can only share the information by email to others. That's what I meant, I'm still waking up after a decent sleep last night

Interesting. I'll have to see if there's a way to include a share button on my newsletter.

Thanks!

Cheers,

Marc

 

[Marc Landers]

Thanks for the reply, when I find something that should be shared with others, sometimes I find I can't share it as there usually isn't a share button, you can only share the information by email to others. That's what I meant, I'm still waking up after a decent sleep last night

Hi Dooby, Our free weekly newsletter just went out, and I noticed there are share buttons at the top on the right, if you want to share from the newsletter.

 

[Dooby Doo]

Hi Dooby, Our free weekly newsletter just went out, and I noticed there are share buttons at the top on the right, if you want to share from the newsletter.

View attachment 186

Thanks Marc, I had a quick read of this article a few days ago, I'll have a proper read tonight, it may have been High and polite I seen this but not as i read from different sites uk and abroad

 

[BudWarrior]

Just skimmed your fifth newsletter summarising some of the cardiac and vascular context

Are you taking suggestions for your content pipeline?

One idea is older/pensionable age cohorts.

Like many people, I introduced older family members to MC. One with serious cardiovascular histories. Interesting conversations about research on THC and CBD impacts came from it.

E.g. how the low quality of research and rampant ignorance leads to over assumptions. Also the clinical inapplicability of half baked science that is detached from the real world, due to things like poor sample construction (should be cohorts by different consumption methods, which has a massive cardiovascular impact).

Other factors included baseless assumptions that ignore substance volumes e.g. I recall one paper that missed the fact that a hypothicated CBD harm (vascular, if I remember correctly) was not just dramatically low probability, The volumes mattered more than they allowed for. The hypothicated risk profile depended on consuming CBD in impossibly silly amounts, with body mass requirements that basically meant something incredibly low risk depended on impossibly high amounts and would need to be in children too.

It was like saying arsenic in apple seeds will kill you, but ignoring that you'd probably die of faecal impaction from the roughage, way before you ingest anywhere near enough seeds/arsenic to be poisoned that way. And nobody would be able to consume that many apple seeds anyway.

 

[Marc Landers]

Just skimmed your fifth newsletter summarising some of the cardiac and vascular context

Are you taking suggestions for your content pipeline?

One idea is older/pensionable age cohorts.

Like many people, I introduced older family members to MC. One with serious cardiovascular histories. Interesting conversations about research on THC and CBD impacts came from it.

E.g. how the low quality of research and rampant ignorance leads to over assumptions. Also the clinical inapplicability of half baked science that is detached from the real world, due to things like poor sample construction (should be cohorts by different consumption methods, which has a massive cardiovascular impact).

Other factors included baseless assumptions that ignore substance volumes e.g. I recall one paper that missed the fact that a hypothicated CBD harm (vascular, if I remember correctly) was not just dramatically low probability, The volumes mattered more than they allowed for. The hypothicated risk profile depended on consuming CBD in impossibly silly amounts, with body mass requirements that basically meant something incredibly low risk depended on impossibly high amounts and would need to be in children too.

It was like saying arsenic in apple seeds will kill you, but ignoring that you'd probably die of faecal impaction from the roughage, way before you ingest anywhere near enough seeds/arsenic to be poisoned that way. And nobody would be able to consume that many apple seeds anyway.

Thanks for that. I'll keep it in mind.